Save information for later
Sign Up

Learn About NUT Carcinoma

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top NUT Carcinoma Local Doctors?
Elite in NUT Carcinoma
Elite in NUT Carcinoma
Plantagenet, ON, CA 

Madeleine Lemieux practices in Plantagenet, Canada. Ms. Lemieux is rated as an Elite expert by MediFind in the treatment of NUT Carcinoma. Her top areas of expertise are NUT Carcinoma, Dilated Cardiomyopathy (DCM), Familial Dilated Cardiomyopathy, and Ewing Sarcoma.

Elite in NUT Carcinoma
Pediatric Hematology Oncology
Elite in NUT Carcinoma
Pediatric Hematology Oncology
450 Brookline Ave, Dana-farber Cancer Institute, 
Boston, MA 
Languages Spoken:
English

Steven Dubois is a Pediatric Hematologist Oncology provider in Boston, Massachusetts. Dr. Dubois is rated as an Elite provider by MediFind in the treatment of NUT Carcinoma. His top areas of expertise are Ewing Sarcoma, Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, and Osteosarcoma.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in NUT Carcinoma
Pediatric Hematology Oncology
Elite in NUT Carcinoma
Pediatric Hematology Oncology
450 Brookline Avenue, Room 1642, 
Boston, MA 
Languages Spoken:
English

Stephen Sallan is a Pediatric Hematologist Oncology provider in Boston, Massachusetts. Dr. Sallan is rated as an Elite provider by MediFind in the treatment of NUT Carcinoma. His top areas of expertise are NUT Carcinoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Adult T-Cell Leukemia.

What are the latest NUT Carcinoma Clinical Trials?
A Phase I/II, Dose-escalation and Dose-optimization Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of MT-4561 in Patients With Various Advanced Solid Tumors and to Evaluate Effect of MT-4561 on Pharmacokinetics of Oral Midazolam

Summary: This is a First In Human (FIH), multicenter, open-label, Phase I/II study to evaluate safety, tolerability, Pharmacokinetics (PK), pharmacodynamics, and efficacy of MT-4561 in patients with advanced solid tumors. This study will be conducted in 3 parts. Part 1 is aimed at evaluating safety, tolerability, PK and pharmacodynamics of MT-4561 and determining the Maximum Tolerated Dose (MTD) using the ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Single Arm Open-Label Pilot Study to Investigate the Safety and Clinical Activity of Cemiplimab, A Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients With Incurable NUT Carcinoma (NC)

Summary: This phase II trial studies how well cemiplimab works in treating patients with nuclear protein of testis (NUT) carcinoma for which no treatment is currently available (incurable) and that has spread from where it first started (primary site) to other places in the body (metastatic) or cannot be removed by surgery (resectable). Immunotherapy with monoclonal antibodies, such as cemiplimab, may help...